Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors

NCT07780539 is registered in ClinicalTrials.gov with Yefeng as lead sponsor.

NCT NCT07780539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07780539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors
Lead sponsor
Yefeng
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
August 31, 2031
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine (ne) tumors